Loading organizations...
§ Private Profile · Singapore, Central Region, Singapore
Digital health platform providing the Aktivo Score, a digital biomarker from wearable data, for individuals and enterprises.
Singapore-based Aktivo Labs provides a business-to-business digital health platform that utilizes real-time smartphone and wearable data to generate proprietary health biomarkers for chronic disease prevention. The enterprise software enables life insurers, health insurers, reinsurers, and corporate wellness programs to offer evidence-based lifestyle interventions while simultaneously accessing aggregated population health analytics. Operating primarily across the Asia-Pacific region with ongoing expansion into the United States and Japan, the company has raised over $10 million in venture funding, including a Series A round led by Mitsui & Co. with participation from SEEDS Capital. Furthermore, the firm licenses its application programming interfaces to global financial enterprises, establishing strategic integrations and commercial partnerships with major industry organizations such as SCOR and Dai-ichi. Aktivo Labs was founded in 2017 by Gourab Mukherjee, David M. Epstein, Professor David Lai, and Dr Meng-Han Kuok.
Aktivo Labs has raised $10.0M across 1 funding round.
Aktivo Labs has raised $10.0M in total across 1 funding round.
Aktivo Labs has raised $10.0M in total across 1 funding round.
Aktivo Labs's investors include Adaptive Capital Partners, SEEDS Capital.
Aktivo Labs has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in October 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 6, 2023 | $10M Series A | Adaptive Capital Partners, Seeds Capital | — | Announced |